UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of Alzheimer's disease, ISSN 1387-2877, 2017, Volume 59, Issue 1, pp. 101 - 111
episodic memory | tau | Amyloid-β | successful cognitive aging | executive function | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging - methods | Alzheimer Disease - complications | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Models, Statistical | Cognitive Dysfunction - etiology | Aged, 80 and over | Female | ROC Curve | Aged | Cognitive Dysfunction - diagnosis | Alzheimer Disease - diagnostic imaging | Cognitive Aging | Neuroimaging | Executive function | Medical imaging | Memory | Cognitive ability | Health risks | Impairment | Pathology | Neurology | Tau protein | Neurodegeneration | Apolipoprotein E | Older people | Aging | Adults | Cognitive tasks | Index Medicus | beta-amyloid
Journal Article
Biological psychiatry (1969), 07/2020
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 2010, Volume 6, Issue 3, pp. 257 - 264
Neurology | Neuroimaging | Cognitive decline | MRI | Mild cognitive impairment | Biomarkers | Cerebrospinal fluid | Clinical trial design | Alzheimer's disease | FDG PET | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cognition Disorders - cerebrospinal fluid | Predictive Value of Tests | Peptide Fragments - cerebrospinal fluid | Prospective Studies | Humans | Clinical Trials as Topic | Hippocampus - pathology | Alzheimer Disease - cerebrospinal fluid | Hippocampus - diagnostic imaging | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Diagnostic Imaging | Radionuclide Imaging | Amyloid beta-Peptides - cerebrospinal fluid | Biomarkers - cerebrospinal fluid | Patient outcomes | Diagnostic imaging | Index Medicus | Alzheimer’s disease | biomarkers | cerebrospinal fluid | clinical trial design | mild cognitive impairment | cognitive decline | neuroimaging
Journal Article
44.
Full Text
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative
Alzheimer's & dementia, ISSN 1552-5260, 07/2015, Volume 11, Issue 7, pp. 730 - 733
Neurology | Biomarkers | Alzheimer's Disease Neuroimaging Initiative | Governance | Tau amyloid PET | Standardization | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - diagnosis | Neuroimaging - methods | Brain - diagnostic imaging | United States | Humans | Positron-Emission Tomography - standards | Brain - pathology | Positron-Emission Tomography - methods | Alzheimer Disease - genetics | Computer Communication Networks | Disease Progression | Neuroimaging - standards | Alzheimer's disease | Diagnostic imaging | Hospitals | Index Medicus
Journal Article
Neurobiology of aging, ISSN 0197-4580, 2015, Volume 36, pp. S203 - S210
Neurology | Internal Medicine | Atrophy | Thickness | MRI | Volume | Vitamin B | Surface area | Homocysteine | Alzheimer's disease | Cortical | Gray matter | Brain structure | Folate | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Alzheimer Disease - etiology | Neuroimaging | Life Style | Humans | Risk Factors | Homocysteine - blood | Male | Biomarkers - blood | Folic Acid - administration & dosage | Vitamin B Complex - administration & dosage | Alzheimer Disease - pathology | Alzheimer Disease - diagnosis | Magnetic Resonance Imaging | Alzheimer Disease - prevention & control | Gray Matter - pathology | Aged, 80 and over | Female | Aged | Diagnostic imaging | Risk factors | Index Medicus
Journal Article
46.
Full Text
A Focus on Structural Brain Imaging in the Alzheimer’s Disease Neuroimaging Initiative
Biological psychiatry (1969), ISSN 0006-3223, 2014, Volume 75, Issue 7, pp. 527 - 533
Psychiatry | magnetic resonance imaging | temporal lobe | Alzheimer’s disease | cognition | hippocampus | MRI | biomarkers | progression | cognitive decline | brain volume | atrophy | dementia | predict | mild cognitive impairment | conversion | Alzheimer's disease | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - diagnosis | Neuroimaging | Magnetic Resonance Imaging | Humans | Biomarkers | Brain - pathology | Cognition | Positron-Emission Tomography | Alzheimer Disease - psychology | Disease Progression | PET imaging | Brain | Index Medicus | Mild Cognitive Impairment
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 2010, Volume 6, Issue 3, pp. 212 - 220
Neurology | ADNI | Magnetic resonance imaging | Alzheimer's disease | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cognition Disorders - cerebrospinal fluid | Brain - diagnostic imaging | Genome-Wide Association Study | Magnetic Resonance Imaging - trends | Alzheimer Disease - complications | Peptide Fragments - cerebrospinal fluid | Cognition Disorders - diagnostic imaging | Humans | Magnetic Resonance Imaging - methods | Positron-Emission Tomography - methods | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - diagnosis | Cognition Disorders - etiology | Amyloid beta-Peptides - cerebrospinal fluid | Brain - pathology | Brain Mapping | Clinical trials | Medical colleges | Neurosciences | Index Medicus
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 07/2015, Volume 11, Issue 7, pp. 850 - 859
Neurology | Neuroimaging | Biomarkers | Cerebrospinal fluid | Alzheimer's disease | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - diagnosis | Biomarkers - cerebrospinal fluid | Global Health | Alzheimer Disease - cerebrospinal fluid | Humans | Medical colleges | Diagnostic imaging | Information management | Hospitals, Military | Public-private sector cooperation | Index Medicus
Journal Article